新型冠状病毒肺炎疫情下糖尿病管理专家建议

doi:10.16150/j.1671-2870.2022.02.006

诊断学理论与实践 ›› 2022, Vol. 21 ›› Issue (02): 136-138.doi: 10.16150/j.1671-2870.2022.02.006

新型冠状病毒肺炎疫情下糖尿病管理专家建议

中华医学会内分泌学分会

国家代谢性疾病临床医学研究中心（上海）

收稿日期:2022-05-26 出版日期:2022-05-30 发布日期:2022-04-25
通讯作者: 中华医学会内分泌学分会

Expert suggestion for diabetes management during the recent COVID-19 pandemic

Chinese Society of Endocrinology,Chinese Medical Association , et al

National Metabolic Diseases Clinical Research Center (Shanghai)

Received:2022-05-26 Online:2022-05-30 Published:2022-04-25
Contact: Chinese Society of Endocrinology,Chinese Medical Association

摘要/Abstract

摘要：

奥密克戎（Omicron）为主要流行株的新一轮新型冠状病毒（新冠）肺炎疫情在世界各地出现。糖尿病作为影响新冠肺炎病情严重程度和死亡结局的重要危险因素,合理的血糖等代谢指标管理尤为重要。为应对疫情下的糖尿病管理,本专家建议的提出,规范从预防和控制感染到血糖等代谢指标等各方面的诊治基本要点,为本轮新冠肺炎疫情期间的糖尿病患者综合管理提供必要的参考依据和指导意见。

关键词: 新型冠状病毒, 奥密克戎, 糖尿病, 血糖管理

Abstract:

Recently, a new Omicron wave of coronavirus disease 2019(COVID-19) pandemic appeared in many places worldwide. Diabetes is one of the important risk factors affecting the severity including mortality of COVID-19. Optimal management of blood glucose and other metabolic parameters is crucial for patients with diabetes. Therefore, this expert′s suggestion aims at providing necessary recommendation and guidance for the comprehensive multifactorial management (from infection prevention and treatment, to metabolic control targets achievement) of diabetes patients during the current COVID-19 pandemic.

Key words: COVID-19, Omicron, Diabetes mellitus, Glycemic control

中图分类号:

R587.1

中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下糖尿病管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 136-138.

Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for diabetes management during the recent COVID-19 pandemic[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 136-138.

参考文献 12

[1]	中国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第九版)[J]. 国际流行病学传染病学杂志, 2022, 49(2):73-80.
	China National Health Commission. Diagnosis and treatment plan for novel coronavirus pneumonia (trial version 9)[J]. Int J Epidemiol Infect Dis, 2022, 49(2):73-80.
[2]	Zhang X, Zhang W, Chen S. Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic[J]. Lancet, 2022, 399(10340):2011-2012. doi: 10.1016/S0140-6736(22)00838-8 URL
[3]	Seiglie J, Platt J, Cromer SJ, et al. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19[J]. Diabetes Care, 2020, 43(12):2938-2944. doi: 10.2337/dc20-1506 URL
[4]	Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study[J]. Lancet Diabetes Endocrinol, 2020, 8(10):813-822. doi: 10.1016/S2213-8587(20)30272-2 URL
[5]	Hartmann-Boyce J, Rees K, Perring JC, et al. Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews[J]. Diabetes Care, 2021, 44(12):2790-2811. doi: 10.2337/dc21-0930 pmid: 34711637
[6]	Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study[J]. Lancet, 2022, 399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0 URL
[7]	Yonekawa A, Shimono N. Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron(B.1.1.529)[J]. Biology (Basel). 2022 Mar 4; 11(3):400.
[8]	Chan JCN, Lim LL, Wareham NJ, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives[J]. Lancet, 2021, 396(10267):2019-2082. doi: 10.1016/S0140-6736(20)32374-6 URL
[9]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4):311-398.
	Diabetes branch of Chinese Medical Association. Guidelines for prevention and treatment of type 2 diabetes in China(2020 Edition)[J]. Chin J Endocrinol Metab, 2021, 37(4):311-398.
[10]	王卫庆, 单忠艳, 王广, 等. 新型冠状病毒肺炎疫情期间糖尿病基层管理专家建议[J]. 中华内分泌代谢杂志, 2020, 36(3):185-190.
	Wang WQ, Shan ZY, Wang G, et al. Expert advice on diabetes management at the grass-roots level during the outbreak of novel coronavirus pneumonia[J]. Chin J Endocrinol Metab, 2020, 36(3):185-190.
[11]	中国医师协会内分泌代谢科医师分会,中国住院患者血糖管理专家组. 中国住院患者血糖管理专家共识[J]. 中华内分泌代谢杂志, 2017, 33(1):1-10.
	Endocrinologist branch of Chinese Medical Association, Chinese inpatient blood glucose management expert group. Consensus of Chinese inpatient blood glucose management experts[J]. Chin J Endocrinol Metab, 2017, 33(1):1-10.
[12]	Zhang Y, Wang W, Ning G. Metabolic Management Center: An innovation project for the management of metabolic diseases and complications in China[J]. J Diabetes, 2019, 11(1):11-13. doi: 10.1111/1753-0407.12847 URL

[1]	石峰, 郭竹英, 郭海艳. 新型冠状病毒肺炎患者外周血淋巴细胞亚群变化的临床意义[J]. 诊断学理论与实践, 2022, 21(05): 619-624.
[2]	上海交通大学医学院附属瑞金医院新冠诊治专家组. 新型冠状病毒奥密克戎变异株感染合并严重基础疾病的救治[J]. 诊断学理论与实践, 2022, 21(02): 105-117.
[3]	新冠病毒定点医院公共学科工作模式撰写组. 上海交通大学医学院附属瑞金医院抗击新型冠状病毒定点医院公共学科工作模式[J]. 诊断学理论与实践, 2022, 21(02): 118-127.
[4]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下甲状腺功能亢进症和甲状腺功能减退症管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 128-129.
[5]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下垂体疾病管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 130-132.
[6]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下骨质疏松症管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 133-135.
[7]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下肾上腺疾病管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 139-142.
[8]	陈长强, 孟俊, 金佩佩, 戴菁. 定点医院新型冠状病毒肺炎患者核酸检测工作的实践和探索[J]. 诊断学理论与实践, 2022, 21(02): 143-149.
[9]	庄蕾, 郑睿智, 高卫益. 某独栋办公楼内新型冠状病毒奥密克戎株聚集性疫情分析[J]. 诊断学理论与实践, 2022, 21(02): 150-153.
[10]	张祎博, 吴文娟, 毕宇芳, 景峰, 顾志冬, 杨之涛, 尚寒冰, 林靖生, 陈尔真. 大型方舱医院感染预防与控制体系的建设和实践探索[J]. 诊断学理论与实践, 2022, 21(02): 165-168.
[11]	丁宁, 陈诗恺, 孟俊, 戴菁, 金佩佩. 新型冠状病毒奥密克戎株核酸检测循环阈值与感染患者转阴周期的相关性及影响因素分析[J]. 诊断学理论与实践, 2022, 21(02): 169-173.
[12]	娄娇, 蒋玲丽, 王寅, 周靖, 胡晓波, 王青. 医学检验实验室在区域新型冠状病毒核酸检测中的质量监管[J]. 诊断学理论与实践, 2022, 21(02): 174-177.
[13]	施莺莺, 钟旭, 刘嘉琳, 何乐, 熊少洁, 翁懿, 丁成唯, 杨溢, 陈伟红, 邱力萍, 辛海光. 新型冠状病毒疫情相关防疫工作人员感染防控实践调查分析及对策[J]. 诊断学理论与实践, 2022, 21(02): 178-183.
[14]	孟俊, 金佩佩, 陈长强, 陈韭铭, 范臻佳, 陈诗恺, 戴菁. 紧急转制的新型冠状病毒感染患者定点收治医院检验科的应急转型经验[J]. 诊断学理论与实践, 2022, 21(02): 184-188.
[15]	蒋琰, 陈婷, 黄晨, 潘培倩, 景峰. 新型冠状病毒感染疫情下急诊内科病区全员应急能力培训方案的构建和实践[J]. 诊断学理论与实践, 2022, 21(02): 189-195.

新型冠状病毒肺炎疫情下糖尿病管理专家建议

Expert suggestion for diabetes management during the recent COVID-19 pandemic

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 12

相关文章 15

编辑推荐

Metrics

本文评价